Leonteq Securities AG’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Leonteq Securities AG's BMY Position: Q2 2026 in Review
Leonteq Securities AG reduced its Bristol-Myers Squibb (BMY) stake by 89% in Q2 2026, selling an estimated $5.74M and leaving 12,628 shares worth $728K. The position accounts for 0.03% of the portfolio, ranked #320.
Leonteq Securities AG first reported a position in BMY in Q1 2021 and has held it in 19 quarters since. The position peaked at $6.83M in Q1 2026. 949 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Leonteq Securities AG held 12,628 shares of Bristol-Myers Squibb worth $728K as of Q2 2026.
- Leonteq Securities AG sold 100,037 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.74M.
- Bristol-Myers Squibb made up 0.03% of Leonteq Securities AG's portfolio in Q2 2026, its #320 holding.
- Leonteq Securities AG first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 19 quarters since.
- Leonteq Securities AG's Bristol-Myers Squibb position peaked at $6.83M in Q1 2026.
- 949 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.